Endocrinology and Metabolism Clinics of North America

Papers
(The TQCC of Endocrinology and Metabolism Clinics of North America is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An Update on the Epidemiology of Type 2 Diabetes213
Postmenopausal Osteoporosis144
Lipid and Lipoprotein Metabolism66
Physiology of Calcium Homeostasis63
Diagnosis of Polycystic Ovary Syndrome51
Prevention of Microvascular Complications of Diabetes41
Assessment of Cardiovascular Disease Risk41
Screening for Diabetes and Prediabetes37
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease34
Diabetes and Osteoporosis31
Pediatric Thyroid Cancer30
New and Emerging Technologies in Type 1 Diabetes29
Osteoporosis26
Anaplastic Thyroid Cancer25
Characterizing Multimorbidity from Type 2 Diabetes23
The Changing Nature of Mortality and Morbidity in Patients with Diabetes21
Cardiometabolic Risk in Polycystic Ovary Syndrome20
Inhaled Corticosteroids and Endocrine Effects in Childhood18
Testosterone Replacement Therapy in Hypogonadal Men18
Definition and Classification of Diabetes and Prediabetes and Emerging Data on Phenotypes17
Regulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of Hypogonadism17
Epidemiology of Male Hypogonadism16
Safety of Statins and Nonstatins for Treatment of Dyslipidemia16
Ethnic Disparities in Diabetes16
Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes15
Dyslipidemia in Diabetes15
Nonclassic Congenital Adrenal Hyperplasia14
Role of Bone Turnover Markers in Osteoporosis Therapy14
Polycystic Ovary Syndrome14
Updates on Osteoporosis in Men14
Hypertriglyceridemia13
Obesity and Aging13
Hereditary Primary Hyperparathyroidism13
Update on Rare Adverse Events from Osteoporosis Therapy and Bisphosphonate Drug Holidays12
Genetics of Polycystic Ovary Syndrome12
Delayed and Precocious Puberty: Genetic Underpinnings and Treatments12
Diabetes and Osteoporosis12
Testosterone, Diabetes Risk, and Diabetes Prevention in Men11
Vitamin D–dependent Hypercalcemia11
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis11
Nonalcoholic Fatty Liver Disease11
Postmenopausal Hyperandrogenism11
100 years of Insulin: Why is Insulin So Expensive and What Can be Done to Control Its Cost?10
Diabetes in Youth10
Management of Women with Polycystic Ovary Syndrome During Pregnancy10
Bone Health in Childhood Chronic Disease10
Evaluating the Impact of Acromegaly on Quality of Life10
Prevention of Type 2 Diabetes10
Hypercalcemia of Malignancy9
Overview of Atypical Diabetes9
Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels9
Phthalate Exposure, Adolescent Health, and the Need for Primary Prevention9
Glucocorticoid- and Transplantation-Induced Osteoporosis9
Testosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic Disease9
Management of Menopause Symptoms and Quality of Life during the Menopause Transition8
Type 1 Diabetes and Aging8
Sexual Dysfunctions in Women7
The Inherited Hypercholesterolemias7
Advances in the Bone Health Assessment of Children7
Pathophysiology of Hypercalcemia7
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota7
Treatment of Hypercalcemia of Malignancy7
Age-Associated Abnormalities of Water Homeostasis7
Hypercalcemia in Pregnancy6
Male Reproduction and Aging6
The Future of Thyroid Nodule Risk Stratification6
Endocrine Sequelae in Childhood Cancer Survivors6
Pathobiology of Metabolic-Associated Fatty Liver Disease6
Root Cause for Metabolic Syndrome and Type 2 Diabetes6
Metabolic-Associated Fatty Liver Disease and Diabetes6
Testicular Dysfunction Among Cancer Survivors6
Drug-Related Hypercalcemia6
Disparities in Thyroid Care6
Symptoms of Late-Onset Hypogonadism in Men6
Thyroid and Aging6
Tertiary and Postrenal Transplantation Hyperparathyroidism6
Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone6
Metabolic-Associated Fatty Liver Disease and Sarcopenia5
Rekindling Hope for Remission5
Use of Testosterone in Postmenopausal Women5
Hormonal Injustice5
Diagnostic and Treatment Considerations for Thyroid Cancer in Women of Reproductive Age and the Perinatal Period5
Disparities in Access to High-Volume Surgeons and Specialized Care5
Lipid Disorders and Metabolic-Associated Fatty Liver Disease5
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism5
Quality of Life in Primary Hyperparathyroidism5
Fertility Issues in Polycystic Ovarian Disease5
Hyperandrogenic Anovulation5
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents5
Assessment of Skeletal Strength5
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease5
Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes5
0.047637939453125